K784-7073 Screening compound: 2-{[(3-bromophenyl)methanesulfonyl]methyl}-N-[2-(morpholin-4-yl)ethyl]-3-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxamide

K784-7073 Screening compound: 2-{[(3-bromophenyl)methanesulfonyl]methyl}-N-[2-(morpholin-4-yl)ethyl]-3-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxamide
K784-7073 Screening compound: 2-{[(3-bromophenyl)methanesulfonyl]methyl}-N-[2-(morpholin-4-yl)ethyl]-3-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K784-7073
2-{[(3-bromophenyl)methanesulfonyl]methyl}-N-[2-(morpholin-4-yl)ethyl]-3-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K784-7073

Molecular Formula

C23H27BrN4O5S (C23 H27 BrN4 O5 S)

Compound Name

2-{[(3-bromophenyl)methanesulfonyl]methyl}-N-[2-(morpholin-4-yl)ethyl]-3-oxo-1,2,3,4-tetrahydroquinoxaline-6-carboxamide

IUPAC name

2-{[(3-bromophenyl)methanesulfonyl]methyl}-N-[2-(morpholin-4-yl)ethyl]-3-oxo-1234-tetrahydroquinoxaline-6-carboxamide

SMILES

O=C(c(cc1)cc(N2)c1NC(CS(Cc1cccc(Br)c1)(=O)=O)C2=O)NCCN1CCOCC1

InChI

InChI=1S/C23H27BrN4O5S/c24-18-3-1-2-16(12-18)14-34(31,32)15-21-23(30)27-20-13-17(4-5-19(20)26-21)22(29)25-6-7-28-8-10-33-11-9-28/h1-5,12-13,21,26H,6-11,14-15H2,(H,25,29)(H,27,30)/t21-/m0/s1

InChI Key

OOPJRADYUJYSSM-NRFANRHFSA-N

MDL Number (MFCD)

MFCD15098656

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

551.46

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.366

Distribution Coefficient, logD

1.351

Water Solubility, LogSw

-2.29

Polar Surface Area

101.544

Acid Dissociation Constant (pKa)

10.45

Base Dissociation Constant (pKb)

5.92

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

39.10

K784-7073 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with K784-7073 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K784-7073?
Check Price and Availability of K784-7073, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K784-7073 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K784-7073
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K784-7073
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K784-7073 available by request